PTH revisited for osteoporosis treatment.
Kessenich
Cathy R
CR
Osteoporosis Testing Center, and University of Florida, Tampa, FL, USA.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D015519:Bone Density / Q000187:drug effects; D005260:Female; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D010024:Osteoporosis / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy*; D010281:Parathyroid Hormone / Q000008:administration & dosage* / Q000009:adverse effects; D019379:Teriparatide / Q000627:therapeutic use; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D010281:Parathyroid Hormone; D019379:Teriparatide